Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novandi Chemistry is a specialized contract research organization (CRO) focused on the development and production of radiolabeled compounds for pharmaceutical research and development. Based in Sweden, the company provides expertise in radiochemistry, particularly with Carbon-11 and Fluorine-18, to support Positron Emission Tomography (PET) imaging studies. Their services encompass the entire radiopharmaceutical development chain, from initial labeling strategy and method development to the production of tracers for preclinical and clinical trials. By enabling precise molecular imaging, Novandi Chemistry helps biopharmaceutical partners accelerate drug discovery and optimize dose-finding through biodistribution and target engagement studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novandi Chemistry.